GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | BCL2L1 | multiple interactions | EXP | | 6480464 | CTD | Folic Acid inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 mRNA]; Folic Acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 mRNA] | PMID:30581319 | BCL2L1 | decreases expression | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | Folic Acid results in decreased expression of BCL2L1 protein | PMID:16595132 | BCL2L1 | increases expression | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | Folic Acid results in increased expression of BCL2L1 mRNA | PMID:25629700 | BCL2L1 | multiple interactions | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | Folic Acid inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form co-treated with MAPT protein mutant form] results in decreased expression of BCL2L1 protein]; TNF protein affects the reaction [Folic Acid results in decreased expression of BCL2L1 protein] | PMID:16595132 PMID:29068127 | |
Go Back to source page | Continue to Ontology report |